A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

Carboplatin AUC6 4 cycles

Description
A document about Lung Cancer - Non-Small Cell (NSCLC).LUNG CANCER – NON-SMALL CELL (NSCLC)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-AUC-6-4-cycles.pdf

Cyclophosphamide and Etoposide

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CYCLOPHOSPHAMIDE and ETOPOSIDE Regimen SCLC - Cyclophosphamide and Etoposide Indication First or second line therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/CyclophosphamideandEtoposide.pdf

Cyclophosphamide, Doxorubicin, Vincristine

Description
Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CYCLOPHOSPHAMIDE-DOXORUBICIN-VINCRISTINE SCLC – Cyclophosphamide-Doxorubicin-Vincristine Indication Second line treatment of SCLC
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/CyclophosphamideDoxorubicinVincristine.pdf

Cisplatin-Etoposide (intravenous and oral)

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CISPLATIN-ETOPOSIDE (Intravenous / Oral) Regimen SCLC – Cisplatin-Etoposide IV/PO Indication Limited stage SCLC
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Cisplatin-Etoposideintravenousandoral.pdf

Carboplatin

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6) 6 CYCLES Regimen  SCLC - Carboplatin (AUC6) 6 Cycles Indication  Second line treatment
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin.pdf

Private patient policy

Description
Private Patient Policy Trust reference Description FIN002 Version number 2 This policy provides guidance on how to administer and account for
Url
/Media/UHS-website-2019/Docs/Policies/Private-patient-policy.pdf

Rapid lateral flow test for COVID-19 before a procedure - patient information

Description
This factsheet provides information about taking a rapid lateral flow test for COVID-19 before your planned procedure
Url
/Media/UHS-website-2019/Patientinformation/COVID-19/Rapid-lateral-flow-test-for-COVID-19-before-a-procedure-3104-PIL.pdf

Cisplatin, Vinorelbine and radiotherapy

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN - VINORELBINE (RADIOTHERAPY) Regimen NSCLC – Cisplatin - Vinorelbine (Radiotherapy) Indication First line therapy of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinVinorelbineandradiotherapyver12.pdf

Cisplatin and Vinorelbine (intravenous-adjuvant)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-VINORELBINE (Intravenous - Adjuvant) Regimen NSCLC – Cisplatin-Vinorelbine (Intravenous-Adjuvant) Indication Adjuvant therapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandVinorelbineintravenous-adjuvantver12.pdf

Cisplatin and Vinorelbine (intravenous)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-VINORELBINE (Intravenous) Regimen NSCLC – Cisplatin-Vinorelbine IV Indication First line therapy of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CisplatinandVinorelbineintravenousver12.pdf
161 to 170 of 668
Previous … 15 16 17 18 19 … Next